Evidence map›Paper›PMID 38059011›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2023

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment.

Miguel Turégano-Yedro, Eva Trillo-Calvo, Fernando Navarro I Ros, José David Maya-Viejo, Cruz González Villaescusa, Jose Maria Echave Sustaeta, Esperanza Doña, Bernardino Alcázar Navarrete

Open access · goldAbstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Determinants of Inhaler Choice at Hospital Discharge.Medical sciences (Basel, Switzerland) · 2026
    Observational
  10. Article
  11. Review
  12. Behavioral Phenotypes of Inhaler Technique and Adherence in COPD: A Cross-Sectional Study.International journal of chronic obstructive pulmonary disease · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Miguel Turégano-YedroCentro de Salud Casar de Cáceres, Casar de Cáceres, Cáceres, Spain.
Eva Trillo-CalvoCentro de Salud Campo de Belchite, Belchite, Zaragoza, Spain.
Fernando Navarro I RosCentro de Salud Ingeniero J Benlloch, Valencia, Spain.
José David Maya-ViejoUnidad de Gestión Clínica de Camas, Distrito Sanitario Aljarafe-Sevilla Norte, Camas, Sevilla, Spain.
Cruz González VillaescusaServicio de Neumología, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Jose Maria Echave SustaetaServicio de Neumología, Hospital Universitario Quironsalud, Universidad Europea de Madrid, Madrid, Spain.
Esperanza DoñaUnidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Regional Universitario de Málaga, Málaga, Spain.
Bernardino Alcázar NavarreteServicio de Neumología, Hospital Universitario Virgen de las Nieves, Granada, Spain.ORCID 0000-0003-2356-9366
Centro de Salud Casa del Barco · ESComplejo Hospitalario de Cáceres · ESDepartamento de Salud · ESHospital Clínico Universitario de Valencia · ESHospital Regional Universitario de Málaga · ESHospital Universitario de Valme · ESHospital Universitario Quirónsalud Madrid · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient's characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD.

Indexed as

Pulmonary Disease, Chronic ObstructiveAdministration, InhalationBronchodilator AgentsHumansMedication AdherenceNebulizers and VaporizersBronchodilator AgentsadherenceCOPDinhaled therapiespersistenceposology

Identifiers

PMID38059011
PMCPMC10697822
OpenAlexW4389307387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.